Chiara Bucciarelli-Ducci1, Dominique Auger2, Carlo Di Mario3, Didier Locca2, Joanna Petryka2, Rory O'Hanlon2, Agata Grasso2, Christine Wright4, Karen Symmonds2, Ricardo Wage2, Eleni Asimacopoulos2, Francesca Del Furia4, Jonathan C Lyne5, Peter D Gatehouse6, Kim M Fox3, Dudley J Pennell7. 1. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom; Bristol Heart Institute, Bristol NIHR Cardiovascular Biomedical Research Unit, University of Bristol, Bristol, United Kingdom. 2. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom. 3. National Heart and Lung Institute, Imperial College, London, United Kingdom; Department of Cardiology, Royal Brompton Hospital, London, United Kingdom. 4. Department of Cardiology, Royal Brompton Hospital, London, United Kingdom. 5. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, Royal Brompton Hospital, London, United Kingdom. 6. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. 7. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address: d.pennell@ic.ac.uk.
Abstract
OBJECTIVES: This study explored whether cardiac magnetic resonance (CMR) could help select patients who could benefit from revascularization by identifying inducible myocardial ischemia and viability in the perfusion territory of the artery with chronic total occlusion (CTO). BACKGROUND: The benefit of revascularization using percutaneous coronary intervention (PCI) in CTO is controversial. CMR offers incomparable left ventricular (LV) systolic function assessment in addition to potent ischemic burden quantification and reliable myocardial viability analysis. Whether CMR guided CTO revascularization would be helpful to such patients has not yet been explored fully. METHODS: A prospective study of 50 consecutive CTO patients was conducted. Of 50 patients undergoing baseline stress CMR, 32 (64%) were selected for recanalization based on the presence of significant inducible perfusion deficit and myocardial viability within the CTO arterial territory. Patients were rescanned 3 months after successful CTO recanalization. RESULTS: At baseline, myocardial perfusion reserve (MPR) in the CTO territory was significantly reduced compared with the remote region (1.8 ± 0.72 vs. 2.2 ± 0.7; p = 0.01). MPR in the CTO region improved significantly after PCI (to 2.3 ± 0.9; p = 0.02 vs. baseline) with complete or near-complete resolution of CTO related perfusion defect in 90% of patients. Remote territory MPR was unchanged after PCI (2.5 ± 1.2; p = NS vs. baseline). The LV ejection fraction increased from 63 ± 13% to 67 ± 12% (p < 0.0001) and end-systolic volume decreased from 65 ± 38 to 56 ± 38 ml (p < 0.001) 3 months after CTO PCI. Importantly, despite minimal post-procedural infarction due to distal embolization and side branch occlusion in 8 of 32 patients (25%), the total Seattle Angina Questionnaire score improved from a median of 54 (range 45 to 74) at baseline to 89 (range 77 to 98) after CTO recanalization (p < 0.0001). CONCLUSIONS: In this small group of patients showing CMR evidence of significant myocardial inducible perfusion defect and viability, CTO recanalization reduces ischemic burden, favors reverse remodeling, and ameliorates quality of life.
OBJECTIVES: This study explored whether cardiac magnetic resonance (CMR) could help select patients who could benefit from revascularization by identifying inducible myocardial ischemia and viability in the perfusion territory of the artery with chronic total occlusion (CTO). BACKGROUND: The benefit of revascularization using percutaneous coronary intervention (PCI) in CTO is controversial. CMR offers incomparable left ventricular (LV) systolic function assessment in addition to potent ischemic burden quantification and reliable myocardial viability analysis. Whether CMR guided CTO revascularization would be helpful to such patients has not yet been explored fully. METHODS: A prospective study of 50 consecutive CTO patients was conducted. Of 50 patients undergoing baseline stress CMR, 32 (64%) were selected for recanalization based on the presence of significant inducible perfusion deficit and myocardial viability within the CTO arterial territory. Patients were rescanned 3 months after successful CTO recanalization. RESULTS: At baseline, myocardial perfusion reserve (MPR) in the CTO territory was significantly reduced compared with the remote region (1.8 ± 0.72 vs. 2.2 ± 0.7; p = 0.01). MPR in the CTO region improved significantly after PCI (to 2.3 ± 0.9; p = 0.02 vs. baseline) with complete or near-complete resolution of CTO related perfusion defect in 90% of patients. Remote territory MPR was unchanged after PCI (2.5 ± 1.2; p = NS vs. baseline). The LV ejection fraction increased from 63 ± 13% to 67 ± 12% (p < 0.0001) and end-systolic volume decreased from 65 ± 38 to 56 ± 38 ml (p < 0.001) 3 months after CTO PCI. Importantly, despite minimal post-procedural infarction due to distal embolization and side branch occlusion in 8 of 32 patients (25%), the total Seattle Angina Questionnaire score improved from a median of 54 (range 45 to 74) at baseline to 89 (range 77 to 98) after CTO recanalization (p < 0.0001). CONCLUSIONS: In this small group of patients showing CMR evidence of significant myocardial inducible perfusion defect and viability, CTO recanalization reduces ischemic burden, favors reverse remodeling, and ameliorates quality of life.
Authors: Bimmer E Claessen; Loes P Hoebers; Joelle E Elias; Ivo M van Dongen; José P S Henriques Journal: J Thorac Dis Date: 2016-09 Impact factor: 2.895
Authors: Amardeep Ghosh Dastidar; Iwan Harries; Giulia Pontecorboli; Vito D Bruno; Estefania De Garate; Charlie Moret; Anna Baritussio; Thomas W Johnson; Elisa McAlindon; Chiara Bucciarelli-Ducci Journal: Int J Cardiovasc Imaging Date: 2018-10-24 Impact factor: 2.357
Authors: Ahmad Syadi Mahmood Zuhdi; Florian Krackhardt; Matthias W Waliszewski; Muhammad Dzafir Ismail; Michael Boxberger; Wan Azman Wan Ahmad Journal: Cardiol Res Pract Date: 2018-03-01 Impact factor: 1.866
Authors: Waleed Salem El Awady; Mohamed Samy; Mohammad Mustafa Al-Daydamony; Magdy Mohammad Abd El Samei; Khaled Abd El Azim Shokry Journal: Egypt Heart J Date: 2020-05-24